Thursday, January 21, 2010

Setback in Democracy

The Supreme Court has just come down with an opinion that opens the floodgates for Corporate Greed to be more powerful than ever! Corporations are now able to pay for political advertising directly instead of using PAC only. This means our Senate, House of Representatives will be purchased by the highest bidder. So this Supreme Court ruling will allow a Pro Republican Corporate takeover of our Government. We need to make noise like never before...PROTEST, PROTEST, PROTEST.


The corporations are NOT citizens and have NO right to freedom of speech on political matters..That is not what our founding fathers intended when they said Freedom of Speech.

This is no joke...Imagine the Bush Years TIMES 1,000!!!!!!!!!

Shorty Awards

I am running for a Shorty Award as @teamvicbo on Twitter please vote for me for a Shorty Award for #nonprofit category for my work for all the 46 million arthritis sufferers, and 300,000 children with Juvenile Arthritis in the USA!

Here's the website: http://shortyawards.com/category/nonprofit#

I just changed my address for this blog

just wanted any followers to notice i finally changed the blog site address to match the name of my blog

Jobs for Disabled

Here's a great article I got through my friend, Rudy Sims, disabilityresourceexchange.com

The concepts in the article is for people in wheelchairs, but the general concepts laid out may be used for anyone who is disabled.

http://www.newdisability.com/jobsfordisabled.htm

Hope this article is useful.

Tuesday, January 19, 2010

Tylenol Recall

ATTENTION Over the Counter drug users: the Tylenol recall has been expanded to include different forms of Tylenol, Benedryl, St Joseph's aspirin, etc

Waning signs are a foul smell when you open bottle.

http://www.arthritistoday.org/news/tylenol-recall-expanded033.php

Tuesday, January 12, 2010

New Drug for Rheumatoid Arthritis approved

Great News! Yet another drug has been approved for Rheumatoid Arthritis.

Associated Press reports: Hal Barron, chief medical officer for Genentech, a division of Swiss owned Roche, claims Actemra “marks a major step forward” in the treatment of the disease. Actemra was first approved in Japan in 2008. It has also been approved in Europe, India, and a handful of other countries.